Phase I Dose-escalation Study of Two Doses GHB04L1 for Pandemic Influenza Prophylaxis in Healthy Adults
Condition: Influenza, Avian Interventions: Biological: GHB04L1; Other: Placebo Sponsor: AVIR Green Hills Biotechnology AG Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials